Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (4.393.218 €): Räumliches Crosstalk in der Immunonkologie Hor03.07.2025 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Räumliches Crosstalk in der Immunonkologie
Metastasis, the leading cause of cancer-related deaths, arises from the spread of cancer cells to distant organs, where they compromise normal organ function. Cellular interactions, paracrine factors, and the metabolic environment promote the formation of metastatic niches that facilitate tumour cell survival and proliferation. While single-cell data have improved our understanding of tumours and their heterogeneity, our knowledge of metastatic niches is still very incomplete. In particular, the lack of spatial context makes it difficult to address critical knowledge gaps in metastatic niche biology which limits our progress in the development of targeted therapeutic interventions. The doctoral network spaXio aims to tackle this challenge by training doctoral candidates (DCs) in cutting-edge techniques, including spatially resolved multi-omics, advanced tumoroid modelling, and computational approaches, including bioinformatics and AI-based prediction models. DCs will conduct systemic analyses of metastatic niches across diverse organ systems and tumour types to improve our understanding of metastatic niche formation and uncover novel therapeutic targets. SpaXio provides comprehensive, multidisciplinary training that combines hands-on laboratory experience, computational data integration, and (industry) secondments. Regular cross-disciplinary workshops and seminars boost innovation and collaboration, while transferable skills training encompasses communication, ethical research, open science, entrepreneurship, and sustainability. By partnering with a network of leading European and international academic, clinical, and industrial experts, spaXio ensures that DCs are exposed to diverse research environments and approaches. This fosters their ability to think across borders, advance technologies and integrate multiple large datasets into a complete systemic picture, preparing them to be leaders in cancer research and shape the rapidly evolving field of spatial biology.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| 10X GENOMICS Inc. | ? |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | 376.251 € |
| Deeplife | 419.559 € |
| EBERHARD KARLS UNIVERSITAET TUEBINGEN | 1.161.089 € |
| Institut National de la Sante et de la Recherche Medicale | 419.559 € |
| Paris-Lodron-Universitat Salzburg | 1.210.172 € |
| TECHNISCHE UNIVERSITAET MUENCHEN | 387.030 € |
| Universite d'AIX Marseille | 419.559 € |
Quelle: https://cordis.europa.eu/project/id/101226364
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der aktuelle Stand wird auf folgender Seite wiedergegeben: 10x Genomics Inc., Pleasanton, USA.
Die Visualisierungen zu "10X GENOMICS Inc. - EU-Förderung (4.393.218 €): Räumliches Crosstalk in der Immunonkologie"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
